Pseudorabies Virus Vaccine Market, Global Outlook and Forecast 2022-2028
Porcine pseudorabies is an acute infectious disease of pigs caused by Pseudorabies virus (PrV). The disease is fulminant in pigs. It can cause abortion of pregnant sows, stillbirth, infertility of boars, death of a large number of newborn piglets, difficulty in breathing of fattening pigs, and stagnant growth. It is one of the major infectious diseases that harm the global pig industry.
This report contains market size and forecasts of Pseudorabies Virus Vaccine in global, including the following market information:
Global Pseudorabies Virus Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pseudorabies Virus Vaccine Market Sales, 2017-2022, 2023-2028, (M Doses)
Global top five Pseudorabies Virus Vaccine companies in 2021 (%)
The global Pseudorabies Virus Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Inactivated Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pseudorabies Virus Vaccine include Merck, Merial Limited, Boehringer Ingelheim Animal Health (USA) Co., Ltd., Zoetis, Hipra, Anhui Divinity Biological Products, Wuhan Keqian Biological Co., Ltd., China Biotechnology Co., Ltd. and CHINA ANIMAL HUSBANDRY INDUSTRY, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pseudorabies Virus Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pseudorabies Virus Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Doses)
Global Pseudorabies Virus Vaccine Market Segment Percentages, by Type, 2021 (%)
Global Pseudorabies Virus Vaccine Market Segment Percentages, by Application, 2021 (%)
Global Pseudorabies Virus Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Pseudorabies Virus Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pseudorabies Virus Vaccine revenues share in global market, 2021 (%)
Key companies Pseudorabies Virus Vaccine sales in global market, 2017-2022 (Estimated), (M Doses)
Key companies Pseudorabies Virus Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Pseudorabies Virus Vaccine in global, including the following market information:
Global Pseudorabies Virus Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pseudorabies Virus Vaccine Market Sales, 2017-2022, 2023-2028, (M Doses)
Global top five Pseudorabies Virus Vaccine companies in 2021 (%)
The global Pseudorabies Virus Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Inactivated Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pseudorabies Virus Vaccine include Merck, Merial Limited, Boehringer Ingelheim Animal Health (USA) Co., Ltd., Zoetis, Hipra, Anhui Divinity Biological Products, Wuhan Keqian Biological Co., Ltd., China Biotechnology Co., Ltd. and CHINA ANIMAL HUSBANDRY INDUSTRY, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pseudorabies Virus Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pseudorabies Virus Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Doses)
Global Pseudorabies Virus Vaccine Market Segment Percentages, by Type, 2021 (%)
- Inactivated Vaccine
- Naturally Deficient Attenuated Vaccine
- Genetic Engineering Vaccine
Global Pseudorabies Virus Vaccine Market Segment Percentages, by Application, 2021 (%)
- Government Tender
- Market Sales
Global Pseudorabies Virus Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Pseudorabies Virus Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pseudorabies Virus Vaccine revenues share in global market, 2021 (%)
Key companies Pseudorabies Virus Vaccine sales in global market, 2017-2022 (Estimated), (M Doses)
Key companies Pseudorabies Virus Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck
- Merial Limited
- Boehringer Ingelheim Animal Health (USA) Co., Ltd.
- Zoetis
- Hipra
- Anhui Divinity Biological Products
- Wuhan Keqian Biological Co., Ltd.
- China Biotechnology Co., Ltd.
- CHINA ANIMAL HUSBANDRY INDUSTRY
- Sichuan Huashen
- Haley
- Tianbang
- Dabei Nong
- Harvey
- Preh Bio
- Jiangsu Nannong High-Tech Co.
- Guangxi Liyuan Biological Co., Ltd.
- Jilin Zhengye Bioengineering Group
- Jilin Heyuan Biological Engineering Co., Ltd.
- Huapai Biological Engineering Group Co., Ltd.
- Beijing Xinde Weite Technology Co., Ltd.
- Beijing Veterinary Biopharmaceutical Factory
- Qilu Animal Health Products Co., Ltd.
- Shanxi Longkel Bio-Pharmaceutical Co., Ltd.
- Yunnan Biopharmaceutical Co.
- Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd.
- Liaoning Yikang Biological Co., Ltd.
- Shanghui Huahong Biological Engineering Co., Ltd.
- Sichuan Hailinge Biological Pharmaceutical Co., Ltd.
- Guangdong Yongshun Biological Pharmaceutical Co., Ltd.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Pseudorabies Virus Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pseudorabies Virus Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PSEUDORABIES VIRUS VACCINE OVERALL MARKET SIZE
2.1 Global Pseudorabies Virus Vaccine Market Size: 2021 VS 2028
2.2 Global Pseudorabies Virus Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Pseudorabies Virus Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Pseudorabies Virus Vaccine Players in Global Market
3.2 Top Global Pseudorabies Virus Vaccine Companies Ranked by Revenue
3.3 Global Pseudorabies Virus Vaccine Revenue by Companies
3.4 Global Pseudorabies Virus Vaccine Sales by Companies
3.5 Global Pseudorabies Virus Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Pseudorabies Virus Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Pseudorabies Virus Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pseudorabies Virus Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Pseudorabies Virus Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Pseudorabies Virus Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Pseudorabies Virus Vaccine Market Size Markets, 2021 & 2028
4.1.2 Inactivated Vaccine
4.1.3 Naturally Deficient Attenuated Vaccine
4.1.4 Genetic Engineering Vaccine
4.2 By Type - Global Pseudorabies Virus Vaccine Revenue & Forecasts
4.2.1 By Type - Global Pseudorabies Virus Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Pseudorabies Virus Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Pseudorabies Virus Vaccine Sales & Forecasts
4.3.1 By Type - Global Pseudorabies Virus Vaccine Sales, 2017-2022
4.3.2 By Type - Global Pseudorabies Virus Vaccine Sales, 2023-2028
4.3.3 By Type - Global Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Pseudorabies Virus Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Pseudorabies Virus Vaccine Market Size, 2021 & 2028
5.1.2 Government Tender
5.1.3 Market Sales
5.2 By Application - Global Pseudorabies Virus Vaccine Revenue & Forecasts
5.2.1 By Application - Global Pseudorabies Virus Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Pseudorabies Virus Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Pseudorabies Virus Vaccine Sales & Forecasts
5.3.1 By Application - Global Pseudorabies Virus Vaccine Sales, 2017-2022
5.3.2 By Application - Global Pseudorabies Virus Vaccine Sales, 2023-2028
5.3.3 By Application - Global Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Pseudorabies Virus Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Pseudorabies Virus Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Pseudorabies Virus Vaccine Revenue & Forecasts
6.2.1 By Region - Global Pseudorabies Virus Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Pseudorabies Virus Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Pseudorabies Virus Vaccine Sales & Forecasts
6.3.1 By Region - Global Pseudorabies Virus Vaccine Sales, 2017-2022
6.3.2 By Region - Global Pseudorabies Virus Vaccine Sales, 2023-2028
6.3.3 By Region - Global Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Pseudorabies Virus Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Pseudorabies Virus Vaccine Sales, 2017-2028
6.4.3 US Pseudorabies Virus Vaccine Market Size, 2017-2028
6.4.4 Canada Pseudorabies Virus Vaccine Market Size, 2017-2028
6.4.5 Mexico Pseudorabies Virus Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Pseudorabies Virus Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Pseudorabies Virus Vaccine Sales, 2017-2028
6.5.3 Germany Pseudorabies Virus Vaccine Market Size, 2017-2028
6.5.4 France Pseudorabies Virus Vaccine Market Size, 2017-2028
6.5.5 U.K. Pseudorabies Virus Vaccine Market Size, 2017-2028
6.5.6 Italy Pseudorabies Virus Vaccine Market Size, 2017-2028
6.5.7 Russia Pseudorabies Virus Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Pseudorabies Virus Vaccine Market Size, 2017-2028
6.5.9 Benelux Pseudorabies Virus Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Pseudorabies Virus Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Pseudorabies Virus Vaccine Sales, 2017-2028
6.6.3 China Pseudorabies Virus Vaccine Market Size, 2017-2028
6.6.4 Japan Pseudorabies Virus Vaccine Market Size, 2017-2028
6.6.5 South Korea Pseudorabies Virus Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Pseudorabies Virus Vaccine Market Size, 2017-2028
6.6.7 India Pseudorabies Virus Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Pseudorabies Virus Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Pseudorabies Virus Vaccine Sales, 2017-2028
6.7.3 Brazil Pseudorabies Virus Vaccine Market Size, 2017-2028
6.7.4 Argentina Pseudorabies Virus Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pseudorabies Virus Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Pseudorabies Virus Vaccine Sales, 2017-2028
6.8.3 Turkey Pseudorabies Virus Vaccine Market Size, 2017-2028
6.8.4 Israel Pseudorabies Virus Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Pseudorabies Virus Vaccine Market Size, 2017-2028
6.8.6 UAE Pseudorabies Virus Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Pseudorabies Virus Vaccine Major Product Offerings
7.1.4 Merck Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Merck Key News
7.2 Merial Limited
7.2.1 Merial Limited Corporate Summary
7.2.2 Merial Limited Business Overview
7.2.3 Merial Limited Pseudorabies Virus Vaccine Major Product Offerings
7.2.4 Merial Limited Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Merial Limited Key News
7.3 Boehringer Ingelheim Animal Health (USA) Co., Ltd.
7.3.1 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Corporate Summary
7.3.2 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Business Overview
7.3.3 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.3.4 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Key News
7.4 Zoetis
7.4.1 Zoetis Corporate Summary
7.4.2 Zoetis Business Overview
7.4.3 Zoetis Pseudorabies Virus Vaccine Major Product Offerings
7.4.4 Zoetis Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Zoetis Key News
7.5 Hipra
7.5.1 Hipra Corporate Summary
7.5.2 Hipra Business Overview
7.5.3 Hipra Pseudorabies Virus Vaccine Major Product Offerings
7.5.4 Hipra Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Hipra Key News
7.6 Anhui Divinity Biological Products
7.6.1 Anhui Divinity Biological Products Corporate Summary
7.6.2 Anhui Divinity Biological Products Business Overview
7.6.3 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Major Product Offerings
7.6.4 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Anhui Divinity Biological Products Key News
7.7 Wuhan Keqian Biological Co., Ltd.
7.7.1 Wuhan Keqian Biological Co., Ltd. Corporate Summary
7.7.2 Wuhan Keqian Biological Co., Ltd. Business Overview
7.7.3 Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.7.4 Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Wuhan Keqian Biological Co., Ltd. Key News
7.8 China Biotechnology Co., Ltd.
7.8.1 China Biotechnology Co., Ltd. Corporate Summary
7.8.2 China Biotechnology Co., Ltd. Business Overview
7.8.3 China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.8.4 China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 China Biotechnology Co., Ltd. Key News
7.9 CHINA ANIMAL HUSBANDRY INDUSTRY
7.9.1 CHINA ANIMAL HUSBANDRY INDUSTRY Corporate Summary
7.9.2 CHINA ANIMAL HUSBANDRY INDUSTRY Business Overview
7.9.3 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Major Product Offerings
7.9.4 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 CHINA ANIMAL HUSBANDRY INDUSTRY Key News
7.10 Sichuan Huashen
7.10.1 Sichuan Huashen Corporate Summary
7.10.2 Sichuan Huashen Business Overview
7.10.3 Sichuan Huashen Pseudorabies Virus Vaccine Major Product Offerings
7.10.4 Sichuan Huashen Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Sichuan Huashen Key News
7.11 Haley
7.11.1 Haley Corporate Summary
7.11.2 Haley Pseudorabies Virus Vaccine Business Overview
7.11.3 Haley Pseudorabies Virus Vaccine Major Product Offerings
7.11.4 Haley Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.11.5 Haley Key News
7.12 Tianbang
7.12.1 Tianbang Corporate Summary
7.12.2 Tianbang Pseudorabies Virus Vaccine Business Overview
7.12.3 Tianbang Pseudorabies Virus Vaccine Major Product Offerings
7.12.4 Tianbang Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.12.5 Tianbang Key News
7.13 Dabei Nong
7.13.1 Dabei Nong Corporate Summary
7.13.2 Dabei Nong Pseudorabies Virus Vaccine Business Overview
7.13.3 Dabei Nong Pseudorabies Virus Vaccine Major Product Offerings
7.13.4 Dabei Nong Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.13.5 Dabei Nong Key News
7.14 Harvey
7.14.1 Harvey Corporate Summary
7.14.2 Harvey Business Overview
7.14.3 Harvey Pseudorabies Virus Vaccine Major Product Offerings
7.14.4 Harvey Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.14.5 Harvey Key News
7.15 Preh Bio
7.15.1 Preh Bio Corporate Summary
7.15.2 Preh Bio Business Overview
7.15.3 Preh Bio Pseudorabies Virus Vaccine Major Product Offerings
7.15.4 Preh Bio Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.15.5 Preh Bio Key News
7.16 Jiangsu Nannong High-Tech Co.
7.16.1 Jiangsu Nannong High-Tech Co. Corporate Summary
7.16.2 Jiangsu Nannong High-Tech Co. Business Overview
7.16.3 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Major Product Offerings
7.16.4 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.16.5 Jiangsu Nannong High-Tech Co. Key News
7.17 Guangxi Liyuan Biological Co., Ltd.
7.17.1 Guangxi Liyuan Biological Co., Ltd. Corporate Summary
7.17.2 Guangxi Liyuan Biological Co., Ltd. Business Overview
7.17.3 Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.17.4 Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.17.5 Guangxi Liyuan Biological Co., Ltd. Key News
7.18 Jilin Zhengye Bioengineering Group
7.18.1 Jilin Zhengye Bioengineering Group Corporate Summary
7.18.2 Jilin Zhengye Bioengineering Group Business Overview
7.18.3 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Major Product Offerings
7.18.4 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.18.5 Jilin Zhengye Bioengineering Group Key News
7.19 Jilin Heyuan Biological Engineering Co., Ltd.
7.19.1 Jilin Heyuan Biological Engineering Co., Ltd. Corporate Summary
7.19.2 Jilin Heyuan Biological Engineering Co., Ltd. Business Overview
7.19.3 Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.19.4 Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.19.5 Jilin Heyuan Biological Engineering Co., Ltd. Key News
7.20 Huapai Biological Engineering Group Co., Ltd.
7.20.1 Huapai Biological Engineering Group Co., Ltd. Corporate Summary
7.20.2 Huapai Biological Engineering Group Co., Ltd. Business Overview
7.20.3 Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.20.4 Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.20.5 Huapai Biological Engineering Group Co., Ltd. Key News
7.21 Beijing Xinde Weite Technology Co., Ltd.
7.21.1 Beijing Xinde Weite Technology Co., Ltd. Corporate Summary
7.21.2 Beijing Xinde Weite Technology Co., Ltd. Business Overview
7.21.3 Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.21.4 Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.21.5 Beijing Xinde Weite Technology Co., Ltd. Key News
7.22 Beijing Veterinary Biopharmaceutical Factory
7.22.1 Beijing Veterinary Biopharmaceutical Factory Corporate Summary
7.22.2 Beijing Veterinary Biopharmaceutical Factory Business Overview
7.22.3 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Major Product Offerings
7.22.4 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.22.5 Beijing Veterinary Biopharmaceutical Factory Key News
7.23 Qilu Animal Health Products Co., Ltd.
7.23.1 Qilu Animal Health Products Co., Ltd. Corporate Summary
7.23.2 Qilu Animal Health Products Co., Ltd. Business Overview
7.23.3 Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.23.4 Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.23.5 Qilu Animal Health Products Co., Ltd. Key News
7.24 Shanxi Longkel Bio-Pharmaceutical Co., Ltd.
7.24.1 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Corporate Summary
7.24.2 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Business Overview
7.24.3 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.24.4 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.24.5 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Key News
7.25 Yunnan Biopharmaceutical Co.
7.25.1 Yunnan Biopharmaceutical Co. Corporate Summary
7.25.2 Yunnan Biopharmaceutical Co. Business Overview
7.25.3 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Major Product Offerings
7.25.4 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.25.5 Yunnan Biopharmaceutical Co. Key News
7.26 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd.
7.26.1 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Corporate Summary
7.26.2 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Business Overview
7.26.3 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.26.4 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.26.5 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Key News
7.27 Liaoning Yikang Biological Co., Ltd.
7.27.1 Liaoning Yikang Biological Co., Ltd. Corporate Summary
7.27.2 Liaoning Yikang Biological Co., Ltd. Business Overview
7.27.3 Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.27.4 Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.27.5 Liaoning Yikang Biological Co., Ltd. Key News
7.28 Shanghui Huahong Biological Engineering Co., Ltd.
7.28.1 Shanghui Huahong Biological Engineering Co., Ltd. Corporate Summary
7.28.2 Shanghui Huahong Biological Engineering Co., Ltd. Business Overview
7.28.3 Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.28.4 Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.28.5 Shanghui Huahong Biological Engineering Co., Ltd. Key News
7.29 Sichuan Hailinge Biological Pharmaceutical Co., Ltd.
7.29.1 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Corporate Summary
7.29.2 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Business Overview
7.29.3 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.29.4 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.29.5 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Key News
7.30 Guangdong Yongshun Biological Pharmaceutical Co., Ltd.
7.30.1 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Corporate Summary
7.30.2 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Business Overview
7.30.3 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.30.4 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.30.5 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Key News
8 GLOBAL PSEUDORABIES VIRUS VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Pseudorabies Virus Vaccine Production Capacity, 2017-2028
8.2 Pseudorabies Virus Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Pseudorabies Virus Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PSEUDORABIES VIRUS VACCINE SUPPLY CHAIN ANALYSIS
10.1 Pseudorabies Virus Vaccine Industry Value Chain
10.2 Pseudorabies Virus Vaccine Upstream Market
10.3 Pseudorabies Virus Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pseudorabies Virus Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Pseudorabies Virus Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pseudorabies Virus Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PSEUDORABIES VIRUS VACCINE OVERALL MARKET SIZE
2.1 Global Pseudorabies Virus Vaccine Market Size: 2021 VS 2028
2.2 Global Pseudorabies Virus Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Pseudorabies Virus Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Pseudorabies Virus Vaccine Players in Global Market
3.2 Top Global Pseudorabies Virus Vaccine Companies Ranked by Revenue
3.3 Global Pseudorabies Virus Vaccine Revenue by Companies
3.4 Global Pseudorabies Virus Vaccine Sales by Companies
3.5 Global Pseudorabies Virus Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Pseudorabies Virus Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Pseudorabies Virus Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pseudorabies Virus Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Pseudorabies Virus Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Pseudorabies Virus Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Pseudorabies Virus Vaccine Market Size Markets, 2021 & 2028
4.1.2 Inactivated Vaccine
4.1.3 Naturally Deficient Attenuated Vaccine
4.1.4 Genetic Engineering Vaccine
4.2 By Type - Global Pseudorabies Virus Vaccine Revenue & Forecasts
4.2.1 By Type - Global Pseudorabies Virus Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Pseudorabies Virus Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Pseudorabies Virus Vaccine Sales & Forecasts
4.3.1 By Type - Global Pseudorabies Virus Vaccine Sales, 2017-2022
4.3.2 By Type - Global Pseudorabies Virus Vaccine Sales, 2023-2028
4.3.3 By Type - Global Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Pseudorabies Virus Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Pseudorabies Virus Vaccine Market Size, 2021 & 2028
5.1.2 Government Tender
5.1.3 Market Sales
5.2 By Application - Global Pseudorabies Virus Vaccine Revenue & Forecasts
5.2.1 By Application - Global Pseudorabies Virus Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Pseudorabies Virus Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Pseudorabies Virus Vaccine Sales & Forecasts
5.3.1 By Application - Global Pseudorabies Virus Vaccine Sales, 2017-2022
5.3.2 By Application - Global Pseudorabies Virus Vaccine Sales, 2023-2028
5.3.3 By Application - Global Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Pseudorabies Virus Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Pseudorabies Virus Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Pseudorabies Virus Vaccine Revenue & Forecasts
6.2.1 By Region - Global Pseudorabies Virus Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Pseudorabies Virus Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Pseudorabies Virus Vaccine Sales & Forecasts
6.3.1 By Region - Global Pseudorabies Virus Vaccine Sales, 2017-2022
6.3.2 By Region - Global Pseudorabies Virus Vaccine Sales, 2023-2028
6.3.3 By Region - Global Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Pseudorabies Virus Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Pseudorabies Virus Vaccine Sales, 2017-2028
6.4.3 US Pseudorabies Virus Vaccine Market Size, 2017-2028
6.4.4 Canada Pseudorabies Virus Vaccine Market Size, 2017-2028
6.4.5 Mexico Pseudorabies Virus Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Pseudorabies Virus Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Pseudorabies Virus Vaccine Sales, 2017-2028
6.5.3 Germany Pseudorabies Virus Vaccine Market Size, 2017-2028
6.5.4 France Pseudorabies Virus Vaccine Market Size, 2017-2028
6.5.5 U.K. Pseudorabies Virus Vaccine Market Size, 2017-2028
6.5.6 Italy Pseudorabies Virus Vaccine Market Size, 2017-2028
6.5.7 Russia Pseudorabies Virus Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Pseudorabies Virus Vaccine Market Size, 2017-2028
6.5.9 Benelux Pseudorabies Virus Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Pseudorabies Virus Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Pseudorabies Virus Vaccine Sales, 2017-2028
6.6.3 China Pseudorabies Virus Vaccine Market Size, 2017-2028
6.6.4 Japan Pseudorabies Virus Vaccine Market Size, 2017-2028
6.6.5 South Korea Pseudorabies Virus Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Pseudorabies Virus Vaccine Market Size, 2017-2028
6.6.7 India Pseudorabies Virus Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Pseudorabies Virus Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Pseudorabies Virus Vaccine Sales, 2017-2028
6.7.3 Brazil Pseudorabies Virus Vaccine Market Size, 2017-2028
6.7.4 Argentina Pseudorabies Virus Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pseudorabies Virus Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Pseudorabies Virus Vaccine Sales, 2017-2028
6.8.3 Turkey Pseudorabies Virus Vaccine Market Size, 2017-2028
6.8.4 Israel Pseudorabies Virus Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Pseudorabies Virus Vaccine Market Size, 2017-2028
6.8.6 UAE Pseudorabies Virus Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Pseudorabies Virus Vaccine Major Product Offerings
7.1.4 Merck Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Merck Key News
7.2 Merial Limited
7.2.1 Merial Limited Corporate Summary
7.2.2 Merial Limited Business Overview
7.2.3 Merial Limited Pseudorabies Virus Vaccine Major Product Offerings
7.2.4 Merial Limited Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Merial Limited Key News
7.3 Boehringer Ingelheim Animal Health (USA) Co., Ltd.
7.3.1 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Corporate Summary
7.3.2 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Business Overview
7.3.3 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.3.4 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Key News
7.4 Zoetis
7.4.1 Zoetis Corporate Summary
7.4.2 Zoetis Business Overview
7.4.3 Zoetis Pseudorabies Virus Vaccine Major Product Offerings
7.4.4 Zoetis Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Zoetis Key News
7.5 Hipra
7.5.1 Hipra Corporate Summary
7.5.2 Hipra Business Overview
7.5.3 Hipra Pseudorabies Virus Vaccine Major Product Offerings
7.5.4 Hipra Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Hipra Key News
7.6 Anhui Divinity Biological Products
7.6.1 Anhui Divinity Biological Products Corporate Summary
7.6.2 Anhui Divinity Biological Products Business Overview
7.6.3 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Major Product Offerings
7.6.4 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Anhui Divinity Biological Products Key News
7.7 Wuhan Keqian Biological Co., Ltd.
7.7.1 Wuhan Keqian Biological Co., Ltd. Corporate Summary
7.7.2 Wuhan Keqian Biological Co., Ltd. Business Overview
7.7.3 Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.7.4 Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Wuhan Keqian Biological Co., Ltd. Key News
7.8 China Biotechnology Co., Ltd.
7.8.1 China Biotechnology Co., Ltd. Corporate Summary
7.8.2 China Biotechnology Co., Ltd. Business Overview
7.8.3 China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.8.4 China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 China Biotechnology Co., Ltd. Key News
7.9 CHINA ANIMAL HUSBANDRY INDUSTRY
7.9.1 CHINA ANIMAL HUSBANDRY INDUSTRY Corporate Summary
7.9.2 CHINA ANIMAL HUSBANDRY INDUSTRY Business Overview
7.9.3 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Major Product Offerings
7.9.4 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 CHINA ANIMAL HUSBANDRY INDUSTRY Key News
7.10 Sichuan Huashen
7.10.1 Sichuan Huashen Corporate Summary
7.10.2 Sichuan Huashen Business Overview
7.10.3 Sichuan Huashen Pseudorabies Virus Vaccine Major Product Offerings
7.10.4 Sichuan Huashen Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Sichuan Huashen Key News
7.11 Haley
7.11.1 Haley Corporate Summary
7.11.2 Haley Pseudorabies Virus Vaccine Business Overview
7.11.3 Haley Pseudorabies Virus Vaccine Major Product Offerings
7.11.4 Haley Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.11.5 Haley Key News
7.12 Tianbang
7.12.1 Tianbang Corporate Summary
7.12.2 Tianbang Pseudorabies Virus Vaccine Business Overview
7.12.3 Tianbang Pseudorabies Virus Vaccine Major Product Offerings
7.12.4 Tianbang Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.12.5 Tianbang Key News
7.13 Dabei Nong
7.13.1 Dabei Nong Corporate Summary
7.13.2 Dabei Nong Pseudorabies Virus Vaccine Business Overview
7.13.3 Dabei Nong Pseudorabies Virus Vaccine Major Product Offerings
7.13.4 Dabei Nong Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.13.5 Dabei Nong Key News
7.14 Harvey
7.14.1 Harvey Corporate Summary
7.14.2 Harvey Business Overview
7.14.3 Harvey Pseudorabies Virus Vaccine Major Product Offerings
7.14.4 Harvey Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.14.5 Harvey Key News
7.15 Preh Bio
7.15.1 Preh Bio Corporate Summary
7.15.2 Preh Bio Business Overview
7.15.3 Preh Bio Pseudorabies Virus Vaccine Major Product Offerings
7.15.4 Preh Bio Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.15.5 Preh Bio Key News
7.16 Jiangsu Nannong High-Tech Co.
7.16.1 Jiangsu Nannong High-Tech Co. Corporate Summary
7.16.2 Jiangsu Nannong High-Tech Co. Business Overview
7.16.3 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Major Product Offerings
7.16.4 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.16.5 Jiangsu Nannong High-Tech Co. Key News
7.17 Guangxi Liyuan Biological Co., Ltd.
7.17.1 Guangxi Liyuan Biological Co., Ltd. Corporate Summary
7.17.2 Guangxi Liyuan Biological Co., Ltd. Business Overview
7.17.3 Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.17.4 Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.17.5 Guangxi Liyuan Biological Co., Ltd. Key News
7.18 Jilin Zhengye Bioengineering Group
7.18.1 Jilin Zhengye Bioengineering Group Corporate Summary
7.18.2 Jilin Zhengye Bioengineering Group Business Overview
7.18.3 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Major Product Offerings
7.18.4 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.18.5 Jilin Zhengye Bioengineering Group Key News
7.19 Jilin Heyuan Biological Engineering Co., Ltd.
7.19.1 Jilin Heyuan Biological Engineering Co., Ltd. Corporate Summary
7.19.2 Jilin Heyuan Biological Engineering Co., Ltd. Business Overview
7.19.3 Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.19.4 Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.19.5 Jilin Heyuan Biological Engineering Co., Ltd. Key News
7.20 Huapai Biological Engineering Group Co., Ltd.
7.20.1 Huapai Biological Engineering Group Co., Ltd. Corporate Summary
7.20.2 Huapai Biological Engineering Group Co., Ltd. Business Overview
7.20.3 Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.20.4 Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.20.5 Huapai Biological Engineering Group Co., Ltd. Key News
7.21 Beijing Xinde Weite Technology Co., Ltd.
7.21.1 Beijing Xinde Weite Technology Co., Ltd. Corporate Summary
7.21.2 Beijing Xinde Weite Technology Co., Ltd. Business Overview
7.21.3 Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.21.4 Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.21.5 Beijing Xinde Weite Technology Co., Ltd. Key News
7.22 Beijing Veterinary Biopharmaceutical Factory
7.22.1 Beijing Veterinary Biopharmaceutical Factory Corporate Summary
7.22.2 Beijing Veterinary Biopharmaceutical Factory Business Overview
7.22.3 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Major Product Offerings
7.22.4 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.22.5 Beijing Veterinary Biopharmaceutical Factory Key News
7.23 Qilu Animal Health Products Co., Ltd.
7.23.1 Qilu Animal Health Products Co., Ltd. Corporate Summary
7.23.2 Qilu Animal Health Products Co., Ltd. Business Overview
7.23.3 Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.23.4 Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.23.5 Qilu Animal Health Products Co., Ltd. Key News
7.24 Shanxi Longkel Bio-Pharmaceutical Co., Ltd.
7.24.1 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Corporate Summary
7.24.2 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Business Overview
7.24.3 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.24.4 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.24.5 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Key News
7.25 Yunnan Biopharmaceutical Co.
7.25.1 Yunnan Biopharmaceutical Co. Corporate Summary
7.25.2 Yunnan Biopharmaceutical Co. Business Overview
7.25.3 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Major Product Offerings
7.25.4 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.25.5 Yunnan Biopharmaceutical Co. Key News
7.26 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd.
7.26.1 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Corporate Summary
7.26.2 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Business Overview
7.26.3 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.26.4 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.26.5 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Key News
7.27 Liaoning Yikang Biological Co., Ltd.
7.27.1 Liaoning Yikang Biological Co., Ltd. Corporate Summary
7.27.2 Liaoning Yikang Biological Co., Ltd. Business Overview
7.27.3 Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.27.4 Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.27.5 Liaoning Yikang Biological Co., Ltd. Key News
7.28 Shanghui Huahong Biological Engineering Co., Ltd.
7.28.1 Shanghui Huahong Biological Engineering Co., Ltd. Corporate Summary
7.28.2 Shanghui Huahong Biological Engineering Co., Ltd. Business Overview
7.28.3 Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.28.4 Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.28.5 Shanghui Huahong Biological Engineering Co., Ltd. Key News
7.29 Sichuan Hailinge Biological Pharmaceutical Co., Ltd.
7.29.1 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Corporate Summary
7.29.2 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Business Overview
7.29.3 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.29.4 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.29.5 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Key News
7.30 Guangdong Yongshun Biological Pharmaceutical Co., Ltd.
7.30.1 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Corporate Summary
7.30.2 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Business Overview
7.30.3 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Major Product Offerings
7.30.4 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales and Revenue in Global (2017-2022)
7.30.5 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Key News
8 GLOBAL PSEUDORABIES VIRUS VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Pseudorabies Virus Vaccine Production Capacity, 2017-2028
8.2 Pseudorabies Virus Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Pseudorabies Virus Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PSEUDORABIES VIRUS VACCINE SUPPLY CHAIN ANALYSIS
10.1 Pseudorabies Virus Vaccine Industry Value Chain
10.2 Pseudorabies Virus Vaccine Upstream Market
10.3 Pseudorabies Virus Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pseudorabies Virus Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Pseudorabies Virus Vaccine in Global Market
Table 2. Top Pseudorabies Virus Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Pseudorabies Virus Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Pseudorabies Virus Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Pseudorabies Virus Vaccine Sales by Companies, (M Doses), 2017-2022
Table 6. Global Pseudorabies Virus Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Pseudorabies Virus Vaccine Price (2017-2022) & (USD/Doses)
Table 8. Global Manufacturers Pseudorabies Virus Vaccine Product Type
Table 9. List of Global Tier 1 Pseudorabies Virus Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pseudorabies Virus Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Pseudorabies Virus Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Pseudorabies Virus Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Pseudorabies Virus Vaccine Sales (M Doses), 2017-2022
Table 15. By Type - Global Pseudorabies Virus Vaccine Sales (M Doses), 2023-2028
Table 16. By Application – Global Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Pseudorabies Virus Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Pseudorabies Virus Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Pseudorabies Virus Vaccine Sales (M Doses), 2017-2022
Table 20. By Application - Global Pseudorabies Virus Vaccine Sales (M Doses), 2023-2028
Table 21. By Region – Global Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Pseudorabies Virus Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Pseudorabies Virus Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Pseudorabies Virus Vaccine Sales (M Doses), 2017-2022
Table 25. By Region - Global Pseudorabies Virus Vaccine Sales (M Doses), 2023-2028
Table 26. By Country - North America Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Pseudorabies Virus Vaccine Sales, (M Doses), 2017-2022
Table 29. By Country - North America Pseudorabies Virus Vaccine Sales, (M Doses), 2023-2028
Table 30. By Country - Europe Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Pseudorabies Virus Vaccine Sales, (M Doses), 2017-2022
Table 33. By Country - Europe Pseudorabies Virus Vaccine Sales, (M Doses), 2023-2028
Table 34. By Region - Asia Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Pseudorabies Virus Vaccine Sales, (M Doses), 2017-2022
Table 37. By Region - Asia Pseudorabies Virus Vaccine Sales, (M Doses), 2023-2028
Table 38. By Country - South America Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Pseudorabies Virus Vaccine Sales, (M Doses), 2017-2022
Table 41. By Country - South America Pseudorabies Virus Vaccine Sales, (M Doses), 2023-2028
Table 42. By Country - Middle East & Africa Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Pseudorabies Virus Vaccine Sales, (M Doses), 2017-2022
Table 45. By Country - Middle East & Africa Pseudorabies Virus Vaccine Sales, (M Doses), 2023-2028
Table 46. Merck Corporate Summary
Table 47. Merck Pseudorabies Virus Vaccine Product Offerings
Table 48. Merck Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 49. Merial Limited Corporate Summary
Table 50. Merial Limited Pseudorabies Virus Vaccine Product Offerings
Table 51. Merial Limited Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 52. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Corporate Summary
Table 53. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 54. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 55. Zoetis Corporate Summary
Table 56. Zoetis Pseudorabies Virus Vaccine Product Offerings
Table 57. Zoetis Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 58. Hipra Corporate Summary
Table 59. Hipra Pseudorabies Virus Vaccine Product Offerings
Table 60. Hipra Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 61. Anhui Divinity Biological Products Corporate Summary
Table 62. Anhui Divinity Biological Products Pseudorabies Virus Vaccine Product Offerings
Table 63. Anhui Divinity Biological Products Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 64. Wuhan Keqian Biological Co., Ltd. Corporate Summary
Table 65. Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 66. Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 67. China Biotechnology Co., Ltd. Corporate Summary
Table 68. China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 69. China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 70. CHINA ANIMAL HUSBANDRY INDUSTRY Corporate Summary
Table 71. CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Product Offerings
Table 72. CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 73. Sichuan Huashen Corporate Summary
Table 74. Sichuan Huashen Pseudorabies Virus Vaccine Product Offerings
Table 75. Sichuan Huashen Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 76. Haley Corporate Summary
Table 77. Haley Pseudorabies Virus Vaccine Product Offerings
Table 78. Haley Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 79. Tianbang Corporate Summary
Table 80. Tianbang Pseudorabies Virus Vaccine Product Offerings
Table 81. Tianbang Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 82. Dabei Nong Corporate Summary
Table 83. Dabei Nong Pseudorabies Virus Vaccine Product Offerings
Table 84. Dabei Nong Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 85. Harvey Corporate Summary
Table 86. Harvey Pseudorabies Virus Vaccine Product Offerings
Table 87. Harvey Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 88. Preh Bio Corporate Summary
Table 89. Preh Bio Pseudorabies Virus Vaccine Product Offerings
Table 90. Preh Bio Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 91. Jiangsu Nannong High-Tech Co. Corporate Summary
Table 92. Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Product Offerings
Table 93. Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 94. Guangxi Liyuan Biological Co., Ltd. Corporate Summary
Table 95. Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 96. Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 97. Jilin Zhengye Bioengineering Group Corporate Summary
Table 98. Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Product Offerings
Table 99. Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 100. Jilin Heyuan Biological Engineering Co., Ltd. Corporate Summary
Table 101. Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 102. Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 103. Huapai Biological Engineering Group Co., Ltd. Corporate Summary
Table 104. Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 105. Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 106. Beijing Xinde Weite Technology Co., Ltd. Corporate Summary
Table 107. Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 108. Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 109. Beijing Veterinary Biopharmaceutical Factory Corporate Summary
Table 110. Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Product Offerings
Table 111. Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 112. Qilu Animal Health Products Co., Ltd. Corporate Summary
Table 113. Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 114. Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 115. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Corporate Summary
Table 116. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 117. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 118. Yunnan Biopharmaceutical Co. Corporate Summary
Table 119. Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Product Offerings
Table 120. Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 121. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Corporate Summary
Table 122. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 123. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 124. Liaoning Yikang Biological Co., Ltd. Corporate Summary
Table 125. Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 126. Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 127. Shanghui Huahong Biological Engineering Co., Ltd. Corporate Summary
Table 128. Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 129. Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 130. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Corporate Summary
Table 131. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 132. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 133. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Corporate Summary
Table 134. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 135. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 136. Pseudorabies Virus Vaccine Production Capacity (M Doses) of Key Manufacturers in Global Market, 2020-2022 (M Doses)
Table 137. Global Pseudorabies Virus Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 138. Global Pseudorabies Virus Vaccine Production by Region, 2017-2022 (M Doses)
Table 139. Global Pseudorabies Virus Vaccine Production by Region, 2023-2028 (M Doses)
Table 140. Pseudorabies Virus Vaccine Market Opportunities & Trends in Global Market
Table 141. Pseudorabies Virus Vaccine Market Drivers in Global Market
Table 142. Pseudorabies Virus Vaccine Market Restraints in Global Market
Table 143. Pseudorabies Virus Vaccine Raw Materials
Table 144. Pseudorabies Virus Vaccine Raw Materials Suppliers in Global Market
Table 145. Typical Pseudorabies Virus Vaccine Downstream
Table 146. Pseudorabies Virus Vaccine Downstream Clients in Global Market
Table 147. Pseudorabies Virus Vaccine Distributors and Sales Agents in Global Market
Table 1. Key Players of Pseudorabies Virus Vaccine in Global Market
Table 2. Top Pseudorabies Virus Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Pseudorabies Virus Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Pseudorabies Virus Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Pseudorabies Virus Vaccine Sales by Companies, (M Doses), 2017-2022
Table 6. Global Pseudorabies Virus Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Pseudorabies Virus Vaccine Price (2017-2022) & (USD/Doses)
Table 8. Global Manufacturers Pseudorabies Virus Vaccine Product Type
Table 9. List of Global Tier 1 Pseudorabies Virus Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pseudorabies Virus Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Pseudorabies Virus Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Pseudorabies Virus Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Pseudorabies Virus Vaccine Sales (M Doses), 2017-2022
Table 15. By Type - Global Pseudorabies Virus Vaccine Sales (M Doses), 2023-2028
Table 16. By Application – Global Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Pseudorabies Virus Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Pseudorabies Virus Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Pseudorabies Virus Vaccine Sales (M Doses), 2017-2022
Table 20. By Application - Global Pseudorabies Virus Vaccine Sales (M Doses), 2023-2028
Table 21. By Region – Global Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Pseudorabies Virus Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Pseudorabies Virus Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Pseudorabies Virus Vaccine Sales (M Doses), 2017-2022
Table 25. By Region - Global Pseudorabies Virus Vaccine Sales (M Doses), 2023-2028
Table 26. By Country - North America Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Pseudorabies Virus Vaccine Sales, (M Doses), 2017-2022
Table 29. By Country - North America Pseudorabies Virus Vaccine Sales, (M Doses), 2023-2028
Table 30. By Country - Europe Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Pseudorabies Virus Vaccine Sales, (M Doses), 2017-2022
Table 33. By Country - Europe Pseudorabies Virus Vaccine Sales, (M Doses), 2023-2028
Table 34. By Region - Asia Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Pseudorabies Virus Vaccine Sales, (M Doses), 2017-2022
Table 37. By Region - Asia Pseudorabies Virus Vaccine Sales, (M Doses), 2023-2028
Table 38. By Country - South America Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Pseudorabies Virus Vaccine Sales, (M Doses), 2017-2022
Table 41. By Country - South America Pseudorabies Virus Vaccine Sales, (M Doses), 2023-2028
Table 42. By Country - Middle East & Africa Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Pseudorabies Virus Vaccine Sales, (M Doses), 2017-2022
Table 45. By Country - Middle East & Africa Pseudorabies Virus Vaccine Sales, (M Doses), 2023-2028
Table 46. Merck Corporate Summary
Table 47. Merck Pseudorabies Virus Vaccine Product Offerings
Table 48. Merck Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 49. Merial Limited Corporate Summary
Table 50. Merial Limited Pseudorabies Virus Vaccine Product Offerings
Table 51. Merial Limited Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 52. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Corporate Summary
Table 53. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 54. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 55. Zoetis Corporate Summary
Table 56. Zoetis Pseudorabies Virus Vaccine Product Offerings
Table 57. Zoetis Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 58. Hipra Corporate Summary
Table 59. Hipra Pseudorabies Virus Vaccine Product Offerings
Table 60. Hipra Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 61. Anhui Divinity Biological Products Corporate Summary
Table 62. Anhui Divinity Biological Products Pseudorabies Virus Vaccine Product Offerings
Table 63. Anhui Divinity Biological Products Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 64. Wuhan Keqian Biological Co., Ltd. Corporate Summary
Table 65. Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 66. Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 67. China Biotechnology Co., Ltd. Corporate Summary
Table 68. China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 69. China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 70. CHINA ANIMAL HUSBANDRY INDUSTRY Corporate Summary
Table 71. CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Product Offerings
Table 72. CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 73. Sichuan Huashen Corporate Summary
Table 74. Sichuan Huashen Pseudorabies Virus Vaccine Product Offerings
Table 75. Sichuan Huashen Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 76. Haley Corporate Summary
Table 77. Haley Pseudorabies Virus Vaccine Product Offerings
Table 78. Haley Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 79. Tianbang Corporate Summary
Table 80. Tianbang Pseudorabies Virus Vaccine Product Offerings
Table 81. Tianbang Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 82. Dabei Nong Corporate Summary
Table 83. Dabei Nong Pseudorabies Virus Vaccine Product Offerings
Table 84. Dabei Nong Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 85. Harvey Corporate Summary
Table 86. Harvey Pseudorabies Virus Vaccine Product Offerings
Table 87. Harvey Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 88. Preh Bio Corporate Summary
Table 89. Preh Bio Pseudorabies Virus Vaccine Product Offerings
Table 90. Preh Bio Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 91. Jiangsu Nannong High-Tech Co. Corporate Summary
Table 92. Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Product Offerings
Table 93. Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 94. Guangxi Liyuan Biological Co., Ltd. Corporate Summary
Table 95. Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 96. Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 97. Jilin Zhengye Bioengineering Group Corporate Summary
Table 98. Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Product Offerings
Table 99. Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 100. Jilin Heyuan Biological Engineering Co., Ltd. Corporate Summary
Table 101. Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 102. Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 103. Huapai Biological Engineering Group Co., Ltd. Corporate Summary
Table 104. Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 105. Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 106. Beijing Xinde Weite Technology Co., Ltd. Corporate Summary
Table 107. Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 108. Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 109. Beijing Veterinary Biopharmaceutical Factory Corporate Summary
Table 110. Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Product Offerings
Table 111. Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 112. Qilu Animal Health Products Co., Ltd. Corporate Summary
Table 113. Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 114. Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 115. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Corporate Summary
Table 116. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 117. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 118. Yunnan Biopharmaceutical Co. Corporate Summary
Table 119. Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Product Offerings
Table 120. Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 121. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Corporate Summary
Table 122. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 123. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 124. Liaoning Yikang Biological Co., Ltd. Corporate Summary
Table 125. Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 126. Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 127. Shanghui Huahong Biological Engineering Co., Ltd. Corporate Summary
Table 128. Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 129. Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 130. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Corporate Summary
Table 131. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 132. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 133. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Corporate Summary
Table 134. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product Offerings
Table 135. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 136. Pseudorabies Virus Vaccine Production Capacity (M Doses) of Key Manufacturers in Global Market, 2020-2022 (M Doses)
Table 137. Global Pseudorabies Virus Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 138. Global Pseudorabies Virus Vaccine Production by Region, 2017-2022 (M Doses)
Table 139. Global Pseudorabies Virus Vaccine Production by Region, 2023-2028 (M Doses)
Table 140. Pseudorabies Virus Vaccine Market Opportunities & Trends in Global Market
Table 141. Pseudorabies Virus Vaccine Market Drivers in Global Market
Table 142. Pseudorabies Virus Vaccine Market Restraints in Global Market
Table 143. Pseudorabies Virus Vaccine Raw Materials
Table 144. Pseudorabies Virus Vaccine Raw Materials Suppliers in Global Market
Table 145. Typical Pseudorabies Virus Vaccine Downstream
Table 146. Pseudorabies Virus Vaccine Downstream Clients in Global Market
Table 147. Pseudorabies Virus Vaccine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Pseudorabies Virus Vaccine Segment by Type
Figure 2. Pseudorabies Virus Vaccine Segment by Application
Figure 3. Global Pseudorabies Virus Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pseudorabies Virus Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pseudorabies Virus Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Pseudorabies Virus Vaccine Sales in Global Market: 2017-2028 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Pseudorabies Virus Vaccine Revenue in 2021
Figure 9. By Type - Global Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Pseudorabies Virus Vaccine Price (USD/Doses), 2017-2028
Figure 12. By Application - Global Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Pseudorabies Virus Vaccine Price (USD/Doses), 2017-2028
Figure 15. By Region - Global Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
Figure 19. US Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
Figure 33. China Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Pseudorabies Virus Vaccine Production Capacity (M Doses), 2017-2028
Figure 49. The Percentage of Production Pseudorabies Virus Vaccine by Region, 2021 VS 2028
Figure 50. Pseudorabies Virus Vaccine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Pseudorabies Virus Vaccine Segment by Type
Figure 2. Pseudorabies Virus Vaccine Segment by Application
Figure 3. Global Pseudorabies Virus Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pseudorabies Virus Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pseudorabies Virus Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Pseudorabies Virus Vaccine Sales in Global Market: 2017-2028 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Pseudorabies Virus Vaccine Revenue in 2021
Figure 9. By Type - Global Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Pseudorabies Virus Vaccine Price (USD/Doses), 2017-2028
Figure 12. By Application - Global Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Pseudorabies Virus Vaccine Price (USD/Doses), 2017-2028
Figure 15. By Region - Global Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
Figure 19. US Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
Figure 33. China Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Pseudorabies Virus Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Pseudorabies Virus Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Pseudorabies Virus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Pseudorabies Virus Vaccine Production Capacity (M Doses), 2017-2028
Figure 49. The Percentage of Production Pseudorabies Virus Vaccine by Region, 2021 VS 2028
Figure 50. Pseudorabies Virus Vaccine Industry Value Chain
Figure 51. Marketing Channels
